Loading...
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
Exenatide (also known as exendin-4) is a glucagon-like peptide-1 mimetic, which is indicated for the treatment of type 2 diabetes mellitus. The currently available formulation of this drug is a twice-daily exenatide (exenatide BID) injection that should be administered within 60 minutes of food. Onc...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047969/ https://ncbi.nlm.nih.gov/pubmed/21437086 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|